Literature DB >> 12571428

Neuropsychological performance in depressed and euthymic bipolar patients.

A Martinez-Aran1, E Vieta, F Colom, M Reinares, A Benabarre, C Torrent, J M Goikolea, B Corbella, J Sánchez-Moreno, M Salamero.   

Abstract

INTRODUCTION: Recent studies have suggested that the presence of persistent cognitive dysfunctions in bipolar patients is not restricted to acute episodes, but they persist even during remission states. Nevertheless, there are several methodological pitfalls in most studies, such as unclear remission criteria, diagnostic heterogeneity or small sample sizes. PATIENTS AND METHODS: Several domains of cognitive function were examined in 30 depressed bipolar patients [DSM-IV criteria for major depression, Hamilton Depression Scale (HDRS) > or =17] and 30 euthymic bipolar patients (at least 6 months of remission, HDRS < or =8 and Young Mania Rating Scale, YMRS < or =6). Psychosocial functioning was assessed through General Assessment of Functioning.
RESULTS: The two groups showed a similar pattern of neuropsychological performance. However, the depressed group was significantly impaired on the Controlled Oral Word Association Test, FAS (COWAT), a measure of verbal fluency, compared with the euthymic group. On the other hand, functional outcome in euthymic patients was related to verbal fluency, even after controlling for residual depressive symptoms.
CONCLUSIONS: Neuropsychological performance was similar in both groups, except for verbal fluency, which was lower in the depressed group. Poor verbal fluency was related to a poor social outcome in euthymic patients. Further research including longitudinal designs aimed at evaluating changes in cognition in these patients is warranted. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12571428     DOI: 10.1159/000068016

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  7 in total

1.  Reliability and Validity of THINC-it in Evaluating Cognitive Function of Patients with Bipolar Depression.

Authors:  Weihua Zhang; Na Zhu; Jianbo Lai; Jingjing Liu; Chee H Ng; Jun Chen; Chao Qian; Yanli Du; Chanchan Hu; Jingkai Chen; Jianbo Hu; Zhong Wang; Hetong Zhou; Yi Xu; Yiru Fang; Chuan Shi; Shaohua Hu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-10-21       Impact factor: 2.570

Review 2.  The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?

Authors:  Isabella Soreca; Ellen Frank; David J Kupfer
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

3.  Neurocognition in bipolar disorder and juvenile bipolar disorder.

Authors:  Catherine M Cahill; Garry Walter; Gin S Malhi
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-08

4.  Fronto-temporal dysregulation in remitted bipolar patients: an fMRI delayed-non-match-to-sample (DNMS) study.

Authors:  Jennifer L Robinson; Carrie E Bearden; E Serap Monkul; Diana Tordesillas-Gutiérrez; Dawn I Velligan; Sophia Frangou; David C Glahn
Journal:  Bipolar Disord       Date:  2009-06       Impact factor: 6.744

5.  Functional outcome assessment in bipolar disorder: A systematic literature review.

Authors:  Maxine Chen; Heather M Fitzgerald; Jessica J Madera; Mauricio Tohen
Journal:  Bipolar Disord       Date:  2019-04-14       Impact factor: 6.744

6.  Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis.

Authors:  Sonia Ruiz de Azua; Carlos Matute; Laura Stertz; Fernando Mosquera; Aitor Palomino; Iris de la Rosa; Sara Barbeito; Patricia Vega; Flávio Kapczinski; Ana González-Pinto
Journal:  BMC Psychiatry       Date:  2013-01-15       Impact factor: 3.630

7.  The Relationship Between Educational Years and Phonemic Verbal Fluency (PVF) and Semantic Verbal Fluency (SVF) Tasks in Spanish Patients Diagnosed With Schizophrenia, Bipolar Disorder, and Psychotic Bipolar Disorder.

Authors:  Eduardo García-Laredo; Fernando Maestú; Miguel Ángel Castellanos; Juan D Molina; Elisa Peréz-Moreno
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.